Empagliflozin and the risk of HF hospitalisation

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

ACC 2019: EMPRISE Study

Published: 04 Jul 2019

Views:
358
Likes:
0

Average (ratings)

No ratings

Your rating

Dr Elisabetta Patorno (Brigham Women's Hospital, Boston, US) discusses the EMPRISE Study - Empagliflozin and the risk of HF hospitalisation in routine clinical care - A first analysis.

Filmed by Radcliffe Cardiology on site at ACC 2019.

Videographer: Josh Birch

Interviewer: Liam O'Neill

This interview was supported by an unrestricted educational grant from Boehringer Ingelheim.